Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus dexamethasone as adjuvants to levobupivacaine for ultrasound-guided interscalene block in shoulder arthroscopy
PACTR202501899436228Phase 4Recruiting
- Sponsor
- Al-Azhar University Hospitals
- Start
- May 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine, dexamethasone and levobupivacaine in Not applicable (2 arms), sponsored by Al-Azhar University Hospitals. Primary endpoint: Cortisol levels and stress response. Started May 2024; status: recruiting.
02
Drugs
dexmedetomidinedexamethasonelevobupivacaine
03
Conditions
Not applicable
Beyond the preview
Go deeper on PACTR202501899436228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202501899436228.